| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/02/2000 | EP1023066A1 Novel pyrazole and pyrazoline substituted compounds |
| 08/02/2000 | EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES |
| 08/02/2000 | EP1023061A1 Somatostatin agonists |
| 08/02/2000 | CN1261881A 6-azauracil derivatives as IL-5 inhibitors |
| 08/02/2000 | CN1261804A Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor |
| 08/02/2000 | CN1054987C Eyedrops for treatment of cataract and producing technology thereof |
| 08/01/2000 | US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043409A2 Alpha-conotoxin peptides |
| 07/27/2000 | WO2000043397A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 07/27/2000 | WO2000043393A1 Novel angiogenesis inhibitors |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043370A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament |
| 07/27/2000 | WO2000043362A1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 07/27/2000 | WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043015A1 Eye drops |
| 07/27/2000 | WO2000043010A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | DE19926890C1 Use of highly fluorinated oligomeric alkanes in ophthalmology, especially as vitreous humor substitutes, retinal tamponade materials, liquid implants, tear fluid substitutes and drug carriers |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2361138A1 Alpha-conotoxin peptides |
| 07/27/2000 | CA2359983A1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2356349A1 Novel angiogenesis inhibitors |
| 07/27/2000 | CA2355168A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | CA2353903A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 07/26/2000 | EP1021553A2 Eukaryotic gene expression cassette and uses thereof |
| 07/26/2000 | EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021406A1 Novel anandamide amidase inhibitors as analgesic agents |
| 07/26/2000 | EP1021402A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 07/26/2000 | EP1021192A1 Dexamethasone gel |
| 07/26/2000 | EP1021184A1 Use of flunarizine for the topical treatment of glaucoma |
| 07/26/2000 | EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity |
| 07/26/2000 | EP1021175A1 Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 07/26/2000 | CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1054751C Oral medicine for curing vision |
| 07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 07/25/2000 | US6093710 Benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 07/25/2000 | US6093561 Human lysophospholipase |
| 07/25/2000 | US6093532 Method for storing a biological organ transplant graft using a benzisoselen-azoline or -azine compound |
| 07/20/2000 | WO2000042220A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 07/20/2000 | WO2000042027A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000041729A1 Remedies for corneal disorders |
| 07/20/2000 | WO2000041692A2 Compositions having improved stability |
| 07/20/2000 | WO2000041680A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 07/20/2000 | WO2000041669A2 Benzimidazole vascular damaging agents |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041469A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS |
| 07/20/2000 | WO2000017358A3 Human chaperone proteins |
| 07/20/2000 | WO2000014097A3 Novel pyranoses |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2360386A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2360358A1 Compositions having improved stability |
| 07/20/2000 | CA2360356A1 .beta.-phenylalanine derivatives as integrin antagonists |
| 07/20/2000 | CA2360227A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 07/20/2000 | CA2359335A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/19/2000 | EP1020219A1 Nanoemulsion based on alkylether citrates and uses thereof in the fields of cosmetics, dermatology, pharmaceuticals and/or ophthalmology |
| 07/19/2000 | EP1019427A1 N?6 -substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019386A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019063A1 Modulation of immune responses |
| 07/19/2000 | EP1019057A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 07/19/2000 | EP1019050A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 07/19/2000 | EP1018884A1 METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS |
| 07/19/2000 | EP1018878A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
| 07/19/2000 | EP0863766B1 Methods for treating injury or degeneration of photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/19/2000 | EP0735877B1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260778A Prostaglandin pharmaceutical compositions |
| 07/19/2000 | CN1260201A Chinese preparatory medicine and its preparation method |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090852 Matrix metalloprotease inhibitor |
| 07/18/2000 | US6090840 Peptidyl compounds having MMP and TNF inhibitory activity |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090825 Oxazole derivatives as antagonists of alpha 1C andrenergic receptors |
| 07/18/2000 | US6090818 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/13/2000 | WO2000040714A2 Therapeutic phosphodiesterase inhibitors |
| 07/13/2000 | WO2000040600A1 Selective inhibitors of mmp-12 |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |